In this study, we demonstrated that TSPAN32 was a key downstream target of BCR-ABL involved in CML pathogenesis via PTEN protein stabilization. This evidence concerns the gene TSPAN32 and chronic myelogenous leukemia, BCR-ABL1 positive.